This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Does cancer screening save lives?
Coordinating data for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Challenge
Questions about the efficacy of screening are key to impacting cancer morbidity and mortality. The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was designed by the National Cancer Institute in the early 1990s to address these questions for the 4 cancers that make up its name.
Solution
Westat has served as the coordinating center for PLCO Cancer Screening Trial since its inception. The trial originally recruited more than 150,000 people aged 50 to 74 at 10 clinical centers, randomized them to a screening or control arm, and continues to follow them longitudinally, collecting data on cancer incidence and mortality.
After 20 years of data collection at each clinical center, the study has moved to centralized follow-up, carried out by Westat.
Westat staff contributed to the report, which appeared in the New England Journal of Medicine, about the results of screening with flexible sigmoidoscopy for colon cancer. Screening was associated with a significant decrease in colon cancer incidence and mortality.
Westat is continuing active data collection with PLCO participants, physicians, and medical records and pathology departments through the Central Data Collection Center (CDCC). The CDCC also conducts passive data collection activities such as submissions to state tumor registries for data linkage and National Death Index searches.
Results
PLCO has already helped researchers answer important questions about the early detection value of PSA testing for prostate cancer, chest X-ray for lung cancer, flexible sigmoidoscopy for colon cancer, and CA125 and ultrasound for ovarian cancer.
Focus Areas
Coordinating Centers Disease Surveillance Multisite Epidemiology Studies Public HealthCapabilities
Biostatistics and Epidemiology Data CollectionSenior Expert Contacts
Sunitha Mathew
Vice President & Practice Director
Barbara O’Brien
Associate Director
-
Perspective
APHA 2023 Recap of Westat’s ActivitiesNovember 2023
Westat staff made a strong impact on the 2023 American Public Health Association (APHA) Annual Meeting & Expo, held in Atlanta, Georgia, November 12-15, 2023!…
-
Perspective
Westat @ APHA 2023November 2023
We’re eager to join our public health colleagues at the American Public Health Association (APHA)’s 2023 Annual Meeting & Expo, in Atlanta, Georgia, November 12-15,…
-
Perspective
Playing a New Role, States Set Visions for Summer LearningNovember 2023
To counter pandemic-related learning loss, the U.S. Department of Education (ED) in March 2021 called on state education agencies (SEAs) and school districts to deliver…